Current Pharmaceutical Challenges in the Treatment and Diagnosis of Neurological Dysfunctions

References

1. RaiA. ShuklaS. GuptaR.K. MishraA. ALS: A silent slayer of motor neurons. Traditional Chinese herbal medicine as an effective therapy.Curr. Pharm. Des.202531171328134610.2174/0113816128329141241205063352
   [Google Scholar]
2. KumarB.S. DineshB.G.H. ShajanS.R.O. Alzheimer’s disease protein targets: Comprehensive review and future directions.Curr. Pharm. Des.202531171347136910.2174/0113816128334916241006195142
   [Google Scholar]
3. WimbartiS. TalleiT.E. KairupanB.H.R. Probing the molecular mechanisms of kratom’s antipsychotic effects through a multi-modal computational approach.Curr. Pharm. Des.202531171370138710.2174/0113816128335217241031033104
   [Google Scholar]
4. MehanS. KumarA. UtageP.R. Efficacy and safety of Altibrain® as an adjunctive therapy for autism spectrum disorder: An open label trial targeting core symptoms.Curr. Pharm. Des.202531171388140110.2174/0113816128335544241210144541
   [Google Scholar]
5. KushawahaS.K. AshawatM.S. AroraR. BaldiA. Auranofin-loaded PLGA nanoparticles for neuroprotection against aluminium-induced Alzheimer’s disease.Curr. Pharm. Des.202531171402141510.2174/0113816128336703241202182209
   [Google Scholar]